Filters
Dietary consumption of tomatoes confers protection against the development of hepatocellular carcinoma that is independent of lycopene intake, and the beneficial effect appears to be pronounced in individuals without chronic hepatitis B virus infection, as shown in a recent study.
Use of nonsteroidal anti‐inflammatory drugs (NSAIDs), except aspirin, is associated with a lower risk of colorectal cancer (CRC) after a negative baseline colonoscopy, a recent study reports.
Once-weekly carfilzomib appears to be optimally beneficial for patients with relapsed and refractory multiple myeloma (RRMM) regardless of baseline disease characteristics, a recent study has shown.
Patients with cancer who develop venous thromboembolism (VTE) could reduce their risk of VTE recurrence with the direct oral anticoagulant (DOAC) apixaban, which demonstrated noninferiority to subcutaneous dalteparin in the Caravaggio* trial.
Volume-based, low-dose computed tomography (CT) screening reduced lung cancer mortality rates in former and current smokers, the Dutch-Belgian NELSON* trial has shown.
Prostate-specific membrane antigen (PSMA) PET-CT offers superior accuracy in identifying pelvic nodal or distant-metastatic disease in men with high-risk prostate cancer and may be a suitable replacement for conventional imaging with CT combined with bone scan, according to results of the proPSMA study.
The addition of the anti-PD-1* monoclonal antibody pembrolizumab to platinum-based neoadjuvant chemotherapy (CT) led to a significant increase in the proportion of women with early triple-negative breast cancer (TNBC) who had a pathological complete response (pCR), the phase III KEYNOTE-522 trial has shown.
